
FOOD ALLERGY FUND PRESENTS
ANNUAL
INNOVATION
— and —
INVESTMENT
SUMMIT
NEW YORK CITY,
APRIL 30 2025
Join us for an in-person experience, highlighting the latest advancements and cutting-edge developments in food allergy research and innovation in 2025.
MEET THE SPEAKERS
-
Del Alfonso
Founder & CEO
Harmony Baby Nutrition -
Dr. James R. Baker
Director, Mary H. Weiser Food Allergy Center
Ruth Dow Doan Professor of Biologic Nanotechnology
Professor Emeritus of Internal Medicine, Medical School and Biomedical Engineering, College of Engineering -
Dr. Stephanie Culler
Co-Founder & CEO
Persephone Biosciences -
Dr. Huw Davis
VP of Business Development
Research Products and Services
Owlstone Medical -
Dr. John Fraser
Founder & CMO
De Motu Cordis Pty. Ltd -
Dr. Daniel Haders II, Ph.D
CEO and Founder
Model Medicines -
Dr. Jeffery A. Hubbell
Vice President, Bioengineering Strategy, New York University
Lead, Initiative to Advance Engineering and Health
Professor, Chemical and Biomolecular Engineering
Professor, Biology
Professor, Grossman School of Medicine
New York University -
Dr. Nikole Kimes
Founder & CEO
Siolta Therapeutics -
Dr. Susan Lynch
Director, Benioff Center for Microbiome Medicine
Professor of Medicine
University of California San Francisco -
Dr. Anne Maitland
Medical Director,
The Ehlers Danlos Institute
Medical University of South Carolina -
Klaus Martin
CEO
Nodal Therapeutics -
Dr. Cathryn R. Nagler
Bunning Family Professor in the Biological Sciences Division, Pritzker School of Molecular Engineering and the College
University of Chicago -
Dr. Carlotta Ronda
Principal Investigator, Microbiome Editing Applications
Innovative Genomics Institute -
Dr. Yoni Savir
Associate Professor
Technion – Israel Institute of Technology -
Ariana Thacker
Founder & President
MoldCo -
Dr. Haris Theoharides
Executive Director, Center of Excellence for Neuroinflammation Research (CENIR), Nova Southeastern University
Professor, Institute for Neuro-Immune Medicine
NSU Florida -
Dr. Christopher M. Warren
Assistant Professor, Preventive Medicine (Epidemiology)
Northwestern University -
Dr. Brian Wong
President & CEO
RAPT Therapeutics